HB5526: Seniors’ Access to Critical Medications Act of 2024

Introduced in House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Referred to the Subcommittee on Health.

Subcommittee Consideration and Mark-up Session Held

Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 19 - 6.

Committee Consideration and Mark-up Session Held

Ordered to be Reported (Amended) by the Yeas and Nays: 41 - 0.

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-691, Part I.

Committee on Ways and Means discharged.

Placed on the Union Calendar, Calendar No. 585.

Mr. Bucshon moved to suspend the rules and pass the bill, as amended.

Considered under suspension of the rules. (consideration: CR H5587-5588)

DEBATE - The House proceeded with forty minutes of debate on H.R. 5526.

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)

Motion to reconsider laid on the table Agreed to without objection.

The title of the measure was amended. Agreed to without objection.

Received in the Senate and Read twice and referred to the Committee on Finance.